These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 18193691)

  • 1. Clinical study with azelnidipine in patients with essential hypertension. Antiarteriosclerotic and cardiac hypertrophy-inhibitory effects and influence on autonomic nervous activity.
    Nada T; Nomura M; Koshiba K; Kawano T; Mikawa J; Ito S
    Arzneimittelforschung; 2007; 57(11):698-704. PubMed ID: 18193691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Azelnidipine is a useful medication for the treatment of heart failure preserved ejection fraction.
    Kiuchi S; Hisatake S; Kabuki T; Oka T; Dobashi S; Fujii T; Ikeda T
    Clin Exp Hypertens; 2017; 39(4):350-354. PubMed ID: 28513286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacological profiles and clinical effects of azelnidipine, a long-acting calcium channel blocker].
    Sada T; Saito H
    Nihon Yakurigaku Zasshi; 2003 Dec; 122(6):539-47. PubMed ID: 14639008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Switching from Cilnidipine to Azelnidipine on Cardiac Sympathetic Nerve Function in Patients with Heart Failure Preserved Ejection Fraction.
    Kiuchi S; Hisatake S; Kabuki T; Oka T; Dobashi S; Fujii T; Ikeda T
    Int Heart J; 2018 Jan; 59(1):120-125. PubMed ID: 29269711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of azelnidipine treatment on left ventricular diastolic performance in patients with hypertension and mild diastolic dysfunction: multi-center study with echocardiography.
    Ito H; Ishii K; Iwakura K; Nakamura F; Nagano T; Takiuchi S
    Hypertens Res; 2009 Oct; 32(10):895-900. PubMed ID: 19680260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of azelnidipine on the autonomic functions and its influence on arterial stiffness and endothelial functions.
    Yamada J; Tomiyama H; Matsumoto C; Yoshida M; Shiina K; Yamashina A
    J Cardiol; 2008 Apr; 51(2):114-20. PubMed ID: 18522784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of combination therapy with olmesartan and azelnidipine on serum osteoprotegerin in patients with hypertension.
    Uzui H; Morishita T; Nakano A; Amaya N; Fukuoka Y; Ishida K; Arakawa K; Lee JD; Tada H
    J Cardiovasc Pharmacol Ther; 2014 May; 19(3):304-9. PubMed ID: 24288395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of new calcium channel blocker, azelnidipine, and amlodipine on baroreflex sensitivity and ambulatory blood pressure.
    Eguchi K; Tomizawa H; Ishikawa J; Hoshide S; Fukuda T; Numao T; Shimada K; Kario K
    J Cardiovasc Pharmacol; 2007 Jun; 49(6):394-400. PubMed ID: 17577104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular effects of azelnidipine in comparison with those of amlodipine assessed in the halothane-anaesthetized dog.
    Ishizaka T; Takahara A; Iwasaki H; Mitsumori Y; Kise H; Nakamura Y; Sugiyama A
    Basic Clin Pharmacol Toxicol; 2010 Feb; 106(2):135-43. PubMed ID: 19906049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.
    Shimada K; Ogihara T; Saruta T; Kuramoto K;
    Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azelnidipine and amlodipine: a comparison of their effects and safety in a randomized double-blinded clinical trial in Chinese essential hypertensive patients.
    Zhao X; Wu F; Jia S; Qu P; Li H; Zhao X; Cao B; Lin Y; Wang M
    Clin Exp Hypertens; 2010; 32(6):372-6. PubMed ID: 21029001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Azelnidipine and Trichlormethiazide in Japanese Type 2 Diabetic Patients with Hypertension: The COAT Randomized Controlled Trial.
    Takihata M; Nakamura A; Kondo Y; Kawasaki S; Kimura M; Terauchi Y
    PLoS One; 2015; 10(5):e0125519. PubMed ID: 25938807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of azelnidipine and amlodipine on exercise-induced sympathoexcitation assessed by pupillometry in hypertensive patients.
    Koike Y; Kawabe T; Nishihara K; Iwane N; Hano T
    Hypertens Res; 2016 Dec; 39(12):863-867. PubMed ID: 27439493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The newly developed calcium antagonist, azelnidipine, increases drain volume in continuous ambulatory peritoneal dialysis patients.
    Suzuki H; Inoue T; Kobayashi K; Shoda J; Nakamoto H
    Adv Perit Dial; 2006; 22():18-23. PubMed ID: 16983932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of calcium channel blockers on glucose tolerance, inflammatory state, and circulating progenitor cells in non-diabetic patients with essential hypertension: a comparative study between azelnidipine and amlodipine on glucose tolerance and endothelial function--a crossover trial (AGENT).
    Fukao K; Shimada K; Hiki M; Kiyanagi T; Hirose K; Kume A; Ohsaka H; Matsumori R; Kurata T; Miyazaki T; Daida H
    Cardiovasc Diabetol; 2011 Sep; 10():79. PubMed ID: 21906391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Azelnidipine decreases sympathetic nerve activity via antioxidant effect in the rostral ventrolateral medulla of stroke-prone spontaneously hypertensive rats.
    Konno S; Hirooka Y; Araki S; Koga Y; Kishi T; Sunagawa K
    J Cardiovasc Pharmacol; 2008 Dec; 52(6):555-60. PubMed ID: 19057394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Azelnidipine reduces urinary protein excretion and urinary liver-type fatty acid binding protein in patients with hypertensive chronic kidney disease.
    Nakamura T; Sugaya T; Kawagoe Y; Suzuki T; Ueda Y; Koide H; Inoue T; Node K
    Am J Med Sci; 2007 Jun; 333(6):321-6. PubMed ID: 17570983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of azelnidipine on home blood pressure and pulse rate in patients with essential hypertension: comparison with amlodipine.
    Yamagishi T
    Hypertens Res; 2006 Oct; 29(10):767-73. PubMed ID: 17283863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Azelnidipine attenuates glomerular damage in Dahl salt-sensitive rats by suppressing sympathetic nerve activity.
    Nagasu H; Satoh M; Fujimoto S; Tomita N; Sasaki T; Kashihara N
    Hypertens Res; 2012 Mar; 35(3):348-55. PubMed ID: 22072106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacological differences in antianginal effects of long-lasting calcium channel blockers: azelnidipine and amlodipine.
    Fujisawa M; Yorikane R; Matsuoka Y; Koike H; Ueno K
    J Cardiovasc Pharmacol; 2013 Jan; 61(1):63-9. PubMed ID: 23288106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.